The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Clark David C since 2005.
The trader's CIK number is 1290061.
At the time of the last reporting, Clark David C was the VP, Finance of Allos Therapeutics Inc. (stock ticker symbol ALTH).
Also see all insider trading activities at Allos Therapeutics Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2012 | ALTH | 0 | $0 | 8,828 | $13,449 | 0 | $0 |
| 2011 | ALTH | 0 | $0 | 7,485 | $14,218 | 0 | $0 |
| 2010 | ALTH | 0 | $0 | 44,725 | $328,809 | 42,000 | $158,679 |
| 2009 | ALTH | 0 | $0 | 70,000 | $490,974 | 70,000 | $183,139 |
| 2005 | ALTH | 272 | $504 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2012-02-29 | ALTH | Sale | 3,388 | 1.52 | 5,163 |
| 2012-03-01 | ALTH | Sale | 3,385 | 1.50 | 5,074 |
| 2012-02-23 | ALTH | Sale | 1,460 | 1.57 | 2,290 |
| 2012-02-24 | ALTH | Sale | 595 | 1.55 | 922 |
| 2011-11-16 | ALTH | Sale | 125 | 1.43 | 178 |
| 2011-11-15 | ALTH | Sale | 5,438 | 1.45 | 7,863 |
| 2011-02-23 | ALTH | Sale | 1,365 | 3.25 | 4,438 |
| 2011-02-24 | ALTH | Sale | 557 | 3.12 | 1,739 |
| 2010-05-10 | ALTH | Option Ex | 3,085 | 2.81 | 8,684 |
| 2010-05-10 | ALTH | Sale | 3,085 | 7.03 | 21,684 |
| 2010-03-10 | ALTH | Option Ex | 20,000 | 4.78 | 95,600 |
| 2010-03-10 | ALTH | Sale | 20,000 | 7.78 | 155,620 |
| 2010-03-04 | ALTH | Option Ex | 8,915 | 2.81 | 25,095 |
| 2010-03-05 | ALTH | Option Ex | 10,000 | 2.93 | 29,300 |
| 2010-03-04 | ALTH | Sale | 11,640 | 6.99 | 81,305 |
| 2010-03-05 | ALTH | Sale | 10,000 | 7.02 | 70,200 |
| 2009-03-13 | ALTH | Option Ex | 5,027 | 2.93 | 14,729 |
| 2009-03-12 | ALTH | Option Ex | 64,973 | 2.59 | 168,410 |
| 2009-03-13 | ALTH | Sale | 5,027 | 7.00 | 35,189 |
| 2009-03-12 | ALTH | Sale | 64,973 | 7.01 | 455,785 |
| 2005-06-30 | ALTH | Buy | 272 | 1.85 | 504 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Clark David C (VP, Finance of Allos Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.